126 related articles for article (PubMed ID: 31560875)
1. Design, synthesis and evaluation of liposomes modified with dendritic aspartic acid for bone-specific targeting.
Zhao Z; Chen C; Xie C; Zhao Y
Chem Phys Lipids; 2020 Jan; 226():104832. PubMed ID: 31560875
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
Yang Y; Zhao Z; Xie C; Zhao Y
Chem Phys Lipids; 2020 May; 228():104882. PubMed ID: 32017901
[TBL] [Abstract][Full Text] [Related]
3. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J
Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968
[TBL] [Abstract][Full Text] [Related]
4. Liposomes modified with a multivalent glutamic hexapeptide: A novel and effective way to promote bone targeting.
Zhao Y; Yang Y; Cui Y; Zhao Z; Chen X
Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300620. PubMed ID: 38133558
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation.
Peng Y; Zhao Y; Chen Y; Yang Z; Zhang L; Xiao W; Yang J; Guo L; Wu Y
Bioorg Med Chem; 2018 Sep; 26(16):4677-4686. PubMed ID: 30098913
[TBL] [Abstract][Full Text] [Related]
6. Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.
Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Tanaka Y; Yamada S; Naito C; Yamamoto A
Biomaterials; 2018 Feb; 154():74-85. PubMed ID: 29120820
[TBL] [Abstract][Full Text] [Related]
7. DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.
Chang Q; Geng R; Wang S; Qu D; Kong X
Drug Deliv; 2016 Nov; 23(9):3629-3638. PubMed ID: 27749106
[TBL] [Abstract][Full Text] [Related]
8. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel.
Zhang B; Xue A; Zhang C; Yu J; Chen W; Sun D
Pharmazie; 2016 Jun; 71(6):320-6. PubMed ID: 27455550
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
[TBL] [Abstract][Full Text] [Related]
10. Liposomes actively recognizing the glucose transporter GLUT
Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
[TBL] [Abstract][Full Text] [Related]
11. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
[TBL] [Abstract][Full Text] [Related]
12. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation.
Bhatt P; Lalani R; Vhora I; Patil S; Amrutiya J; Misra A; Mashru R
Int J Pharm; 2018 Jan; 536(1):95-107. PubMed ID: 29175440
[TBL] [Abstract][Full Text] [Related]
13. Liposils: An effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silica.
Ingle SG; Pai RV; Monpara JD; Vavia PR
Eur J Pharm Sci; 2018 Sep; 122():51-63. PubMed ID: 29936087
[TBL] [Abstract][Full Text] [Related]
14. Liprosomes loading paclitaxel for brain-targeting delivery by intravenous administration: in vitro characterization and in vivo evaluation.
Tang B; Fang G; Gao Y; Liu Y; Liu J; Zou M; Cheng G
Int J Pharm; 2014 Nov; 475(1-2):416-27. PubMed ID: 25218393
[TBL] [Abstract][Full Text] [Related]
15. Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma.
Liu Q; Zhou L; Lu R; Yang C; Wang S; Hai L; Wu Y
Bioorg Med Chem; 2021 Jan; 29():115852. PubMed ID: 33189509
[TBL] [Abstract][Full Text] [Related]
16. The construction and characterization of hybrid paclitaxel-in-micelle-in-liposome systems for enhanced oral drug delivery.
Li Y; Chen Z; Cui Y; Zhai G; Li L
Colloids Surf B Biointerfaces; 2017 Dec; 160():572-580. PubMed ID: 29028605
[TBL] [Abstract][Full Text] [Related]
17. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
18. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
Wang X; Deng L; Chen X; Pei H; Cai L; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Mar; 100(3):1196-205. PubMed ID: 20860011
[TBL] [Abstract][Full Text] [Related]
19. Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation.
Fu YC; Fu TF; Wang HJ; Lin CW; Lee GH; Wu SC; Wang CK
Acta Biomater; 2014 Nov; 10(11):4583-4596. PubMed ID: 25050775
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution.
Xu Y; Meng H
Artif Cells Nanomed Biotechnol; 2016; 44(1):350-5. PubMed ID: 25162671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]